美天生物 (833833.OC)

+ 收藏

现金流量表(美天生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 45,007,577.31104,080,761.0551,356,760.23177,138,921.0056,979,835.01
 收到的税费返还(元) 241,977.69248,842.46105,257.07290,205.88291,404.51
 收到其他与经营活动有关的现金(元) 2,058,233.852,460,016.161,555,545.681,142,733.45902,725.86
 经营活动现金流入小计(元) 47,307,788.85106,789,619.6753,017,562.98178,571,860.3358,173,965.38
 购买商品、接受劳务支付的现金(元) 27,192,983.1647,455,375.8631,640,339.2599,448,182.6835,340,996.84
 支付给职工以及为职工支付的现金(元) 14,268,398.9136,239,481.8217,564,992.5836,075,579.9713,903,006.64
 支付的各项税费(元) 642,631.085,333,626.153,562,963.544,761,693.051,815,121.64
 支付其他与经营活动有关的现金(元) 2,338,378.897,012,001.262,539,453.927,806,357.272,285,755.80
 经营活动现金流出小计(元) 44,442,392.0496,040,485.0955,307,749.29148,091,812.9753,344,880.92
 经营活动产生的现金流量净额(元) 2,865,396.8110,749,134.58-2,290,186.3130,480,047.364,829,084.46
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -8,849.56-27,126.00-
 投资活动现金流入小计(元) -8,849.56-27,126.00-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 2,434,910.904,743,769.053,308,619.496,986,090.974,841,429.80
 投资活动现金流出小计(元) 2,434,910.904,743,769.053,308,619.496,986,090.974,841,429.80
 投资活动产生的现金流量净额(元) -2,434,910.90-4,734,919.49-3,308,619.49-6,958,964.97-4,841,429.80
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---5,730,000.005,730,000.00
 取得借款收到的现金(元) 19,900,000.0045,300,000.0025,300,000.0044,825,000.0025,825,000.00
 收到其他与筹资活动有关的现金(元) 14,555,284.8248,269,862.3925,373,768.1120,286,295.0620,625,950.65
 筹资活动现金流入小计(元) 34,455,284.8293,569,862.3950,673,768.1170,841,295.0652,180,950.65
 偿还债务支付的现金(元) 24,950,000.0046,550,000.0019,400,000.0055,675,000.0024,250,000.00
 分配股利、利润或偿付利息支付的现金(元) 1,326,764.988,216,773.831,158,751.023,324,456.991,764,265.93
 支付其他与筹资活动有关的现金(元) 10,089,333.3638,688,385.1812,698,814.5133,981,699.4316,232,946.03
 筹资活动现金流出小计(元) 36,366,098.3493,455,159.0133,257,565.5392,981,156.4242,247,211.96
 筹资活动产生的现金流量净额(元) -1,910,813.52114,703.3817,416,202.58-22,139,861.369,933,738.69
四、汇率变动对现金及现金等价物的影响(元) 65,931.73-2,697.25-29,102.50137,226.66-9,681.02
五、现金及现金等价物净增加额(元) -1,414,395.886,126,221.2211,788,294.281,518,447.699,911,712.33
 加:期初现金及现金等价物余额(元) 8,573,746.612,447,525.392,447,525.39929,077.70929,077.70
 期末现金及现金等价物余额(元) 7,159,350.738,573,746.6114,235,819.672,447,525.3910,840,790.03
补充资料:
 净利润(元) -15,059,852.18-16,621,271.461,149,450.4111,266,242.972,525,727.55
 资产减值准备(元) -9,066,474.55--570.46-
 固定资产和投资性房地产折旧(元) 8,985,760.1618,379,433.179,182,552.5918,297,632.339,237,191.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 8,985,760.1618,379,433.179,182,552.5918,297,632.339,237,191.72
 无形资产摊销(元) 76,087.44152,174.8876,087.44152,174.8876,087.44
 处置固定资产、无形资产和其他长期资产的损失(元) -795.44--14,013.07-
 固定资产报废损失(元) 58,708.911,872.181,872.18135,451.39130,318.65
 财务费用(元) 1,326,791.732,804,522.651,177,911.323,417,316.261,812,982.05
 投资损失(元) 92,939.79-67,260.27-48,716.12
 递延所得税(元) 1,267,231.75-1,280,732.03-16,554.82-45,297.9271,890.56
  其中:递延所得税资产减少(元) 1,267,231.75-1,280,732.03-16,554.82-45,297.9271,890.56
 存货的减少(元) 1,872,037.43-2,840,326.43-12,942,844.01-5,081,358.09-4,464,328.44
 经营性应收项目的减少(元) 2,606,264.024,727,779.552,140,554.34-4,512,900.78-2,571,847.46
 经营性应付项目的增加(元) 1,727,676.18-3,965,626.91-3,024,612.945,727,420.39-2,127,120.28
 其他(元) -458,400.00-859,500.00-
 现金的期末余额(元) 7,159,350.738,573,746.6114,235,819.672,447,525.3910,840,790.03
 减:现金的期初余额(元) 8,573,746.612,447,525.392,447,525.39929,077.70929,077.70
 现金及现金等价物的净增加额(元) -1,414,395.886,126,221.2211,788,294.281,518,447.699,911,712.33
公告日期 2024-08-272024-04-262023-08-182023-04-242022-08-24
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院